Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

For once, we’ve been using a new diabetes app with regularity. It's called Meal Memory (free for Apple, Android devices), and it revolves around a super simple concept:...
“There are still too many people who do not have access to a life-saving product that was discovered 95 years ago...”
A new bill would put limits on fast food calories, fat, and sugar in kids’ meals.
Plus, how the field of diabetes can learn from the environmental movement.
Bringing accountability and investor thinking to big health challenges. Plus, Q&A with Founder Esther Dyson.
Take action to share your opinion on food labeling with the FDA!
Full-length feature documentary to wrap up in 2017.
Help overcome one of researchers’ major challenges: recruiting participants.
Plus, turning our eyes to the future in 2016!
The hardest part about motivation is that everyone needs something different, and motivators can change over time. But for most of us with diabetes, motivation needs to...
Transforming patient stories into an inspirational theater program across the US.
In J&J’s most recent quarterly update call, we learned of plans to launch the Calibra Finesse bolus-only, wearable insulin delivery device in the US in 2016. The...
Currently enrolling! How does the pill form of this drug class compare to injected GLP-1s?
Agency seeks to integrate patient views in regulating devices.
What this news means for the future of data integration, and what the “real magic” will be down the road.
What were the risks and benefits of this drug?
Dexcom and Google just announced that they have joined forces to develop a next generation of continuous glucose monitors (CGM) that will be smaller and less expensive...
The two organizations expand their research partnership to support glucose responsive insulin.
More flexible data viewing, customizable alarms, excellent Clarity analysis software, and why expectations are so high.
ADA, CDC, AMA, and the Ad Council just launched the first-ever national PSA campaign targeting prediabetes awareness and prevention - plus, three short video ads!

Pages